Seeing Is Believing
Currently out of the existing stock ratings of Jason Bednar, 247 are a BUY (75.3%), 73 are a HOLD (22.26%), 8 are a SELL (2.44%).
Analyst Jason Bednar, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 49.96% that have a potential upside of 22.68% achieved within 120 days.
Jason Bednar’s has documented 647 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ICUI, ICU Medical at 09-Sep-2025.
Analyst best performing recommendations are on VAPO (VAPOTHERM).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 11/3/2022. The price target of $8 was fulfilled within 1 day with a profit of $2.08 (20.63%) receiving and performance score of 206.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$155
$24.55 (18.82%)
$215
6 days ago
(15-Oct-2025)
10/18 (55.56%)
$25.16 (19.38%)
123
Buy
$170
$39.55 (30.32%)
$245
9 days ago
(12-Oct-2025)
11/14 (78.57%)
$40.46 (31.23%)
332
Buy
$140
$9.55 (7.32%)
$200
12 days ago
(09-Oct-2025)
4/5 (80%)
$14.21 (11.30%)
158
Buy
$160
$29.55 (22.65%)
$200
14 days ago
(07-Oct-2025)
6/15 (40%)
$26.91 (20.22%)
239
Buy
$199
$68.55 (52.55%)
$246
2 months 21 days ago
(30-Jul-2025)
0/3 (0%)
$69.99 (54.25%)
Which stock is Jason Bednar is most bullish on?
Which stock is Jason Bednar is most reserved on?
What Year was the first public recommendation made by Jason Bednar?